Oncotarget · 2014 · 32 citations · 29 references
MedicineCancer BiologyOncologyCancer PharmacologyMolecular OncologyStem Cell BiologyCancer Cell SignalingCancer Stem Cell BiologyCancer Stem Cell MaintenanceCancer Stem CellsMetastatic Breast CancerTranslational Cancer ResearchCancer Stem Cell Signaling PathwaysCancer Stem Cell SurvivalCancer Stem Cell TargetingCell Death In CancerDormant Cancer Stem CellsEukaryotic Translation Initiation FactorsTumor Metastasis Biology
// Tingfang Yi 1 , Eihab Kabha 1 , Evangelos Papadopoulos 1 and Gerhard Wagner 1 1 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA Correspondence: Gerhard Wagner, email: // Keywords : cancer stem cells, eIF4E, translation, 4EGI-1 Received : May 29, 2014 Accepted : June 17, 2014 Published : June 18, 2014 Abstract Cancer death is a leading cause of global mortality. An estimated 14.1 million new cancer cases and 8.2 million cancer deaths occurred worldwide in 2012 alone. Cancer stem cells (CSCs) within tumors are essential for tumor metastasis and reoccurrence, the key factors of cancer lethality. Here we report that 4EGI-1, an inhibitor of the interaction between translation initiation factors eIF4E1 and eIF4G1 effectively inhibits breast CSCs through selectively reducing translation persistent in breast CSCs. Translation initiation factor eIF4E1 is significantly enhanced in breast CSCs in comparison to non-CSC breast cancer cells. 4EGI-1 presents increased cytotoxicity to breast CSCs compared to non-CSC breast cancer cells. 4EGI-1 promotes breast CSC differentiation and represses breast CSC induced tube-like structure formation of human umbilical vein endothelial cells (HUVECs). 4EGI-1 isomers suppress breast CSC tumorangiogenesis and tumor growth in vivo. In addition, 4EGI-1 decreases proliferation in and induces apoptosis into breast CSC tumor cells. Furthermore, 4EGI-1 selectively inhibits translation of mRNAs encoding NANOG, OCT4, CXCR4, c-MYC and VEGF in breast CSC tumors. Our study demonstrated that 4EGI-1 targets breast CSCs through selective inhibition of translation critical for breast CSCs, suggesting that selective translation initiation interference might be an avenue targeting CSCs within tumors.
29
Prospective identification of tumorigenic breast cancer cells
Muhammad Al‐Hajj, Max S. Wicha, Adalberto Benito‐Hernández et al. · Proceedings of the National Academy of Sciences · 2003 · 10.4K citations · Full text
Medicine, Cell Biology, Oncology +11
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Sendurai A. Mani, Wenjun Guo, Mai-Jing Liao et al. · Cell · 2008 · 8.7K citations · Full text
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao, Qiulian Wu, Roger E. McLendon et al. · Nature · 2006 · 6.4K citations
Medicine, Cancer Biology, Oncology +16
Involvement of chemokine receptors in breast cancer metastasis
Anja Müller, Bernhard Homey, Hortensia Soto et al. · Nature · 2001 · 5.3K citations
Medicine, Cancer Biology, Oncology +14
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn, Robert W. Cho, Neethan A. Lobo et al. · Nature · 2009 · 2.5K citations · Full text
Medicine, Cancer Biology, Oncology +14